Vesicare
Vesicare helps reduce symptoms of an overactive bladder, such as frequent urination and sudden urges to urinate.
Form
tabletti, kalvopäällysteinen
Strength
5 mg
Active Ingredient
Solifenacin succinate
Manufacturer
Astellas Pharma a/s
How to Use
Dosage
The usual dose is one 5 mg tablet once a day; your doctor may increase it to 10 mg once a day if needed.
Method
Swallow the tablets whole with water. You can take them with or without food.
Important
The maximum daily dose is 10 mg.
Possible Side Effects
COMMON
- •Dry mouth
- •Blurred vision
- •Constipation
- •Nausea
- •Indigestion
- •Stomach pain
RARE
- •Urinary tract infection
- •Drowsiness
- •Dry eyes
- •Dry nose or throat
- •Heartburn
- •Tiredness
- •Swelling in legs
- •Vomiting
- •Headache
- •Itching
- •Rash
- •Hallucinations
- •Confusion
- •Fast heartbeat
- •Muscle weakness
Important Warnings
- If you have difficulty emptying your bladder completely (urinary retention).
- If you have a severe stomach or bowel condition.
- If you have a muscle weakness condition called myasthenia gravis.
- If you have high eye pressure and your vision is getting worse (glaucoma).
- If you are allergic to solifenacin or any other ingredient in this medicine.
Show 4 more warnings
- If you have severe kidney or liver disease, especially if you are taking certain other medicines.
- This medicine should not be given to children or adolescents under 18 years of age.
- Vesicare may cause blurred vision, drowsiness, or tiredness, which can affect your ability to drive or operate machinery.
- If you experience a severe allergic reaction (angioedema), such as swelling of your face, tongue, or throat, difficulty swallowing or breathing, or hives, stop taking the medicine and contact your doctor immediately.
Use in Elderly Patients
Category D
Avoid use in older adults. Anticholinergic. Reduce the dose in severe renal impairment. Significant adverse effects include tachycardia, confusion and cognitive impairment.. Consider the risk of QT prolongation especially when combined with other QT-prolonging drugs. Increases risk of falls. Reduces the effectiveness of drugs for Alzheimer’s disease. (updated 25.11.2024)